Form 4: Twist Bioscience SVP Sells Shares to Cover Tax Obligations Following RSU Vesting
Insider Transaction Report
Paula Green, SVP of Human Resources at Twist Bioscience Corp, sold 853 shares of common stock on June 6, 2025, at $31.75 per share to satisfy tax withholding obligations related to Restricted Stock Unit vesting.
Summary
- Paula Green, the Senior Vice President of Human Resources at Twist Bioscience Corp (TWST), reported a transaction on June 6, 2025.
- She disposed of 853 shares of Twist Bioscience common stock at a price of $31.75 per share.
- The sale was explicitly identified as a 'sell to cover' transaction, which is mandated by the issuer's equity incentive plans to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).
- The filing clarifies that this transaction does not represent a discretionary trade by Ms. Green.
- Following this reported transaction, Ms. Green beneficially owns 127,895 shares of Twist Bioscience common stock.
Sentiment
Score: 5
Explanation: The transaction is a routine 'sell to cover' for tax purposes related to RSU vesting, indicating a neutral sentiment as it does not reflect discretionary trading by the insider and is a standard part of equity compensation.
Positives
- The vesting of Restricted Stock Units (RSUs) indicates that the employee has met certain performance or tenure conditions, which can be seen as a positive for employee retention and alignment with company goals.
Negatives
- No direct negatives identified as the sale was a non-discretionary transaction for tax purposes, not a reflection of insider sentiment regarding the company's prospects.
Risks
- NA
Future Outlook
NA
Management Comments
- Management clarified that the sale of shares was a non-discretionary 'sell to cover' transaction, mandated by the company's equity incentive plans to satisfy tax withholding obligations related to RSU vesting, and does not represent a discretionary trade by the reporting person.
Industry Context
This Form 4 filing details a routine insider transaction related to equity compensation, which is common across all industries for publicly traded companies. It does not provide information relevant to broader industry trends or competitive dynamics.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | NA | NA | NA | NA |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| NA | NA | NA | NA |
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: The sale of 853 shares is a very small fraction of the company's outstanding stock and is unlikely to have a material impact on share price or ownership structure.
- Employees: The vesting of RSUs and subsequent 'sell to cover' transaction is a standard component of executive compensation, reinforcing the company's equity incentive plans and demonstrating the realization of equity value.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 06/06/2025 | Date of transaction: sale of 853 shares of common stock by Paula Green. |
| 06/10/2025 | Date the Form 4 filing was signed by the attorney-in-fact for Paula Green. |
Recommendation
holdKeywords
Twist Bioscience, TWST, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding, Paula Green, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.